SAILIFE · Sai Life Sciences Limited · Financials
Volume · Nov 13
123.33K
Avg daily vol (3M)
93.88K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
21.92B
+29.4%
FY2026
Net Income
3.49B
+105.1%
FY2026
Operating Cash Flow
5.09B
+62.1%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 23.71B | 21.92B | 16.95B |
| INR | 1.83B | 1.67B | 1.39B |
| INR | 361.01M | 392.39M | 761.64M |
| INR | 5.03B | 4.66B | 2.28B |
| INR | 1.26B | 1.17B | 575.71M |
| INR | 2.03B | 3.49B | 1.7B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.